JP2024542944A5 - - Google Patents
Info
- Publication number
- JP2024542944A5 JP2024542944A5 JP2024523232A JP2024523232A JP2024542944A5 JP 2024542944 A5 JP2024542944 A5 JP 2024542944A5 JP 2024523232 A JP2024523232 A JP 2024523232A JP 2024523232 A JP2024523232 A JP 2024523232A JP 2024542944 A5 JP2024542944 A5 JP 2024542944A5
- Authority
- JP
- Japan
- Prior art keywords
- antigen
- nanobody
- binding fragment
- sequence
- polypeptide construct
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111208871.9 | 2021-10-18 | ||
| CN202111208871.9A CN115991782A (zh) | 2021-10-18 | 2021-10-18 | 抗间皮素纳米抗体及其用途 |
| PCT/CN2022/125135 WO2023066133A1 (zh) | 2021-10-18 | 2022-10-13 | 抗间皮素纳米抗体及其用途 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024542944A JP2024542944A (ja) | 2024-11-19 |
| JP2024542944A5 true JP2024542944A5 (https=) | 2025-10-17 |
Family
ID=85989010
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024523232A Pending JP2024542944A (ja) | 2021-10-18 | 2022-10-13 | 抗メソテリンナノボディおよびその使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240417452A1 (https=) |
| EP (1) | EP4421095A4 (https=) |
| JP (1) | JP2024542944A (https=) |
| KR (1) | KR20240099295A (https=) |
| CN (1) | CN115991782A (https=) |
| AU (1) | AU2022373543A1 (https=) |
| CA (1) | CA3235697A1 (https=) |
| MX (1) | MX2024004702A (https=) |
| WO (1) | WO2023066133A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116466097B (zh) * | 2023-06-14 | 2023-08-29 | 天津市协和医药科技集团有限公司 | 一种人胰岛素检测试剂盒 |
| CN117843793B (zh) * | 2024-03-07 | 2024-07-09 | 深圳真实生物医药科技有限公司 | 抗间皮素抗体、抗原结合片段及其用途 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103819559B (zh) * | 2013-12-10 | 2016-02-24 | 中国科学院武汉病毒研究所 | 一种抗间皮素纳米抗体及其编码基因和该纳米抗体的用途 |
| ES2918501T3 (es) * | 2013-12-19 | 2022-07-18 | Novartis Ag | Receptores de antígenos quiméricos de mesotelina humana y usos de los mismos |
| CN108129566B (zh) * | 2017-12-31 | 2021-05-11 | 中国科学院武汉病毒研究所 | 靶向间皮素的c-型单域抗体及其制备方法与应用 |
| GB201811415D0 (en) * | 2018-07-12 | 2018-08-29 | F Star Beta Ltd | Anti-Mesothelin Anti bodies |
| CN109467605A (zh) * | 2018-11-07 | 2019-03-15 | 南京卡提医学科技有限公司 | 嵌合抗原受体DAP12-T2A-CD8α-MSLN scFv-NKp44及其用途 |
| KR20220035908A (ko) * | 2019-06-19 | 2022-03-22 | 실버백 테라퓨틱스, 인크. | 항-메소텔린 항체 및 이의 면역접합체 |
| CN110698562B (zh) * | 2019-10-31 | 2022-10-25 | 浙江蓝盾药业有限公司 | 抗人msln单克隆抗体 |
-
2021
- 2021-10-18 CN CN202111208871.9A patent/CN115991782A/zh active Pending
-
2022
- 2022-10-13 AU AU2022373543A patent/AU2022373543A1/en active Pending
- 2022-10-13 EP EP22882743.2A patent/EP4421095A4/en active Pending
- 2022-10-13 US US18/702,317 patent/US20240417452A1/en active Pending
- 2022-10-13 MX MX2024004702A patent/MX2024004702A/es unknown
- 2022-10-13 KR KR1020247016339A patent/KR20240099295A/ko active Pending
- 2022-10-13 WO PCT/CN2022/125135 patent/WO2023066133A1/zh not_active Ceased
- 2022-10-13 JP JP2024523232A patent/JP2024542944A/ja active Pending
- 2022-10-13 CA CA3235697A patent/CA3235697A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI708788B (zh) | 雙特異性抗體 | |
| JP7842703B2 (ja) | 抗Ｃｌａｕｄｉｎ１８．２抗体およびその使用 | |
| CN119490599A (zh) | 用于治疗癌症的dll3/cd3结合蛋白 | |
| CN113412281B (zh) | Btn3a结合蛋白及其用途 | |
| JP7711208B2 (ja) | Ｄｌｌ３に対する結合分子及びその使用 | |
| EP2760471A2 (en) | Therapeutic peptides | |
| CN110770252A (zh) | 抗p53抗体 | |
| CN113227148B (zh) | 抗gpc3抗体、其抗原结合片段及其医药用途 | |
| JP2023523600A (ja) | ヒトプログラム細胞死リガンド１（ｐｄ－ｌ１）を標的とする単一可変ドメイン抗体およびその誘導体 | |
| CN116940599A (zh) | 抗体融合蛋白及其应用 | |
| JP2024542944A5 (https=) | ||
| CN109678950B (zh) | spink1抗原、能够特异性结合spink1的抗体及其功能片段及其应用和产品 | |
| JP2025513930A5 (https=) | ||
| WO2024017326A1 (zh) | 抗gprc5d纳米抗体及其应用 | |
| JP2025525408A (ja) | 二重特異性抗体及びその応用 | |
| EP4174086A1 (en) | Antibody specifically binding to lgals3bp, and use thereof | |
| JP2024508597A5 (https=) | ||
| WO2022078490A1 (zh) | 抗erbb3抗体或其抗原结合片段及其医药用途 | |
| CN117510636B (zh) | Gprc5d抗体及其应用 | |
| JP7851924B2 (ja) | 抗ｔｒｏｐ－２抗体、その抗原結合断片又はその変異体、及びそれらの医学的使用 | |
| US12331133B2 (en) | Therapeutic antibodies for treating lung cancer | |
| HK40049006A (en) | Anti-gpc3 antibody, antigen-binding fragment thereof, and medical use thereof | |
| HK40049006B (en) | Anti-gpc3 antibody, antigen-binding fragment thereof, and medical use thereof | |
| WO2022144025A1 (zh) | 一种抗erbb3受体的抗体或其抗原结合片段及其医药用途 | |
| CN121021699A (zh) | 抗cldn6的纳米抗体及其相关应用 |